Seed Biotech Revenue and Competitors
Estimated Revenue & Valuation
- Seed Biotech's estimated annual revenue is currently $1.6M per year.
- Seed Biotech's estimated revenue per employee is $155,000
Employee Data
- Seed Biotech has 10 Employees.
- Seed Biotech grew their employee count by 0% last year.
Seed Biotech's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Director Continuous Improvement | Reveal Email/Phone |
3 | Quality Assurance Supervisor | Reveal Email/Phone |
Seed Biotech Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.7M | 11 | -8% | N/A | N/A |
#2 | $14.9M | 96 | -6% | N/A | N/A |
#3 | $15.2M | 98 | 3% | $1.8M | N/A |
#4 | $1.6M | 10 | 0% | N/A | N/A |
#5 | $3.4M | 22 | 0% | N/A | N/A |
#6 | $2.8M | 18 | 50% | N/A | N/A |
#7 | $7.4M | 48 | -2% | N/A | N/A |
#8 | $0.8M | 5 | 0% | N/A | N/A |
#9 | $1.6M | 10 | 0% | N/A | N/A |
#10 | $16.3M | 105 | 62% | N/A | N/A |
What Is Seed Biotech?
Seed Biotech Inc., a Texas Corporation, is a biological material derived product manufacturer, with core operations in Dallas, Texas. Seed Biotech was created for the purpose of pioneering advanced research, development, production, and effective use of intelligently designed biological material based products. Seed Biotech’s proprietary decellularization process has been shown to preserve the native extracellular matrix (ECM) and noncellularconstituents such as the basement membrane, fibrous proteins, and non-fibrous proteins, glycosaminoglycans and proteoglycans. Please check out our website at www.seedbiotech.com for more information on our current products.
keywords:N/AN/A
Total Funding
10
Number of Employees
$1.6M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.5M | 10 | -9% | N/A |
#2 | $1M | 10 | -33% | N/A |
#3 | $1.8M | 10 | N/A | N/A |
#4 | $0.9M | 10 | N/A | N/A |
#5 | $0.9M | 10 | N/A | N/A |